• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有多囊卵巢综合征的青春期女孩非酒精性脂肪性肝病的临床预测评分(PCOS-HS指数)。

Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index).

作者信息

Carreau Anne-Marie, Pyle Laura, Garcia-Reyes Yesenia, Rahat Haseeb, Vigers Tim, Jensen Thomas, Scherzinger Ann, Nadeau Kristen J, Cree-Green Melanie

机构信息

Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

出版信息

Clin Endocrinol (Oxf). 2019 Oct;91(4):544-552. doi: 10.1111/cen.14062. Epub 2019 Aug 16.

DOI:10.1111/cen.14062
PMID:31301251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6744335/
Abstract

OBJECTIVE

Nonalcoholic fatty liver disease (NAFLD) is common in obese adolescents with polycystic ovary syndrome (PCOS), but there are no inexpensive ways to accurately identify NAFLD in PCOS. The objective was to develop a simple clinical score to screen for NAFLD risk in obese adolescents with PCOS.

DESIGN

This is a secondary analysis of 3 cross-sectional studies on metabolic characterization of obese adolescents with PCOS. 108 overweight and obese adolescents with PCOS (BMI > 90th percentile, age 12-19 years) were enrolled from 2012 to 2018.

METHODS

Magnetic resonance imaging was used to quantify hepatic fat fraction (HFF). A development cohort of 87 girls were divided by presence of NAFLD (HFF > 5.5%). A logistic regression model with the outcome of NAFLD and candidate predictor variables was fit. A simplified model (PCOS-HS index) was created using backwards stepdown elimination. Validation was performed using 200 bootstrapped sample and in a second cohort of 21 PCOS participants.

RESULTS

52% of the development cohort had NAFLD. The PCOS-HS index that included BMI percentile, waist circumference, ALT and SHBG had an AUCROC of 0.81, sensitivity 82%, specificity 69%, negative predictive value (NPV) 78% and positive predictive value 74%, using a threshold of 0.44 to predict HS. A threshold of 0.15 ruled out NAFLD with a NPV 90%. In the validation cohort, the model showed an accuracy of 81%, sensitivity of 91% and specificity of 70%.

CONCLUSIONS

We developed a clinical index to identify NAFLD in girls with PCOS who would need further evaluation and treatment.

摘要

目的

非酒精性脂肪性肝病(NAFLD)在患有多囊卵巢综合征(PCOS)的肥胖青少年中很常见,但目前尚无廉价方法能准确识别PCOS患者中的NAFLD。本研究旨在开发一种简单的临床评分系统,用于筛查患有PCOS的肥胖青少年的NAFLD风险。

设计

这是一项对3项关于患有PCOS的肥胖青少年代谢特征的横断面研究的二次分析。2012年至2018年纳入了108名超重和肥胖的PCOS青少年(BMI>第90百分位数,年龄12 - 19岁)。

方法

采用磁共振成像定量肝脏脂肪分数(HFF)。将87名女孩的开发队列按是否存在NAFLD(HFF>5.5%)进行分组。构建一个以NAFLD为结果变量、候选预测变量为自变量的逻辑回归模型。采用向后逐步淘汰法创建一个简化模型(PCOS - HS指数)。使用200个自抽样样本以及在另一组21名PCOS参与者中进行验证。

结果

开发队列中52%的人患有NAFLD。包含BMI百分位数、腰围、谷丙转氨酶(ALT)和性激素结合球蛋白(SHBG)的PCOS - HS指数,其曲线下面积(AUCROC)为0.81,敏感性为82%,特异性为69%,阴性预测值(NPV)为78%,阳性预测值为74%,使用阈值0.44来预测HS。阈值0.15排除NAFLD时NPV为90%。在验证队列中,该模型的准确率为81%,敏感性为91%,特异性为70%。

结论

我们开发了一种临床指数,用于识别患有PCOS且需要进一步评估和治疗的女孩中的NAFLD。

相似文献

1
Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index).患有多囊卵巢综合征的青春期女孩非酒精性脂肪性肝病的临床预测评分(PCOS-HS指数)。
Clin Endocrinol (Oxf). 2019 Oct;91(4):544-552. doi: 10.1111/cen.14062. Epub 2019 Aug 16.
2
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.非酒精性脂肪性肝病与多囊卵巢综合征女性的胰岛素抵抗及脂质堆积产物相关。
Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. Epub 2016 Apr 12.
3
Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.超重/肥胖多囊卵巢综合征青少年中,2 型糖尿病患者非酒精性脂肪性肝病患病率随 2 型糖尿病增加。
J Pediatr Endocrinol Metab. 2023 Apr 17;36(5):441-446. doi: 10.1515/jpem-2022-0527. Print 2023 May 25.
4
Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.与其他女孩和男孩相比,患有非酒精性脂肪性肝病加多囊卵巢综合征的青春期女孩的不良代谢表型。
J Gastroenterol Hepatol. 2016 May;31(5):980-7. doi: 10.1111/jgh.13241.
5
Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?非酒精性脂肪性肝病与多囊卵巢综合征必然相关而非偶然相关的证据:一种新的肝-卵巢轴?
Endocrine. 2016 Feb;51(2):211-21. doi: 10.1007/s12020-015-0640-8. Epub 2015 May 30.
6
Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.多囊卵巢综合征患者的非酒精性脂肪性肝病。
Curr Pharm Des. 2018;24(38):4593-4597. doi: 10.2174/1381612825666190117100751.
7
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.多囊卵巢综合征女性的非酒精性脂肪性肝病:巴西单一中心的相关因素及无创纤维化分期
Arch Endocrinol Metab. 2020 May-Jun;64(3):235-242. doi: 10.20945/2359-3997000000242.
8
Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome.多囊卵巢综合征女性与女童的非酒精性脂肪性肝病。
J Clin Endocrinol Metab. 2022 Jan 1;107(1):258-272. doi: 10.1210/clinem/dgab658.
9
MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.内分泌疾病管理:多囊卵巢综合征和非酒精性脂肪性肝病。
Eur J Endocrinol. 2017 Sep;177(3):R145-R158. doi: 10.1530/EJE-16-1063.
10
Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women.腹部肥胖作为超声和瞬时弹性成像评估多囊卵巢综合征和健康女性非酒精性脂肪肝的预测因子。
Biomed Res Int. 2019 Aug 4;2019:9047324. doi: 10.1155/2019/9047324. eCollection 2019.

引用本文的文献

1
Association of polycystic ovary syndrome with endothelial health, cardiovascular risk, and cellular aging.多囊卵巢综合征与内皮健康、心血管风险及细胞衰老的关联。
Fertil Steril. 2025 Jun;123(6):1123-1132. doi: 10.1016/j.fertnstert.2025.01.006. Epub 2025 Jan 15.
2
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome.多囊卵巢综合征中的系统性低度慢性炎症及内在机制
Front Immunol. 2024 Dec 19;15:1470283. doi: 10.3389/fimmu.2024.1470283. eCollection 2024.
3
Impact of Comorbid Polycystic Ovary Syndrome on Clinical and Laboratory Parameters in Female Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study.合并多囊卵巢综合征对代谢功能障碍相关脂肪性肝病女性青少年临床及实验室指标的影响:一项横断面研究
J Clin Med. 2024 Oct 2;13(19):5885. doi: 10.3390/jcm13195885.
4
Diagnostic Accuracy of Transient Elastography in Hepatosteatosis in Youth With Obesity.瞬时弹性成像对肥胖青少年肝脂肪变性的诊断准确性
J Endocr Soc. 2024 Jun 11;8(7):bvae110. doi: 10.1210/jendso/bvae110. eCollection 2024 May 23.
5
Predicting polycystic ovary syndrome with machine learning algorithms from electronic health records.基于电子健康记录的机器学习算法预测多囊卵巢综合征。
Front Endocrinol (Lausanne). 2024 Jan 30;15:1298628. doi: 10.3389/fendo.2024.1298628. eCollection 2024.
6
Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study.多囊卵巢综合征青少年的肝因子谱:一项病例对照研究。
J Clin Med. 2023 Sep 4;12(17):5744. doi: 10.3390/jcm12175744.
7
Unraveling the Interplay between Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome in Adolescents: Pathogenesis, Prevalence, and Management Strategies.解析青少年非酒精性脂肪性肝病与多囊卵巢综合征的相互作用:发病机制、流行率及管理策略。
Med Sci Monit. 2023 Jul 17;29:e940398. doi: 10.12659/MSM.940398.
8
Dysregulation of immune response in PCOS organ system.多囊卵巢综合征器官系统中免疫反应失调。
Front Immunol. 2023 May 5;14:1169232. doi: 10.3389/fimmu.2023.1169232. eCollection 2023.
9
The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome.基于多囊卵巢综合征女性的性激素结合球蛋白水平,用于区分胰岛素抵抗的稳态模型评估胰岛素抵抗指数的临界值。
Front Med (Lausanne). 2023 Mar 10;10:1100547. doi: 10.3389/fmed.2023.1100547. eCollection 2023.
10
The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study.多囊卵巢综合征青少年非酒精性脂肪性肝病的负担:一项病例对照研究。
J Clin Med. 2023 Jan 10;12(2):557. doi: 10.3390/jcm12020557.

本文引用的文献

1
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.非酒精性脂肪性肝病:病因、诊断、心血管代谢后果和治疗策略。
Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324. doi: 10.1016/S2213-8587(18)30154-2. Epub 2018 Aug 30.
2
A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis.多囊卵巢综合征与非酒精性脂肪性肝病之间的潜在联系:一项更新的荟萃分析。
Reprod Health. 2018 May 10;15(1):77. doi: 10.1186/s12978-018-0519-2.
3
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.MRI-PDFF 无创定量评估肝脂肪作为 NASH 试验的终点。
Hepatology. 2018 Aug;68(2):763-772. doi: 10.1002/hep.29797.
4
Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome.非肥胖型多囊卵巢综合征女孩的胰岛素抵抗、高胰岛素血症与线粒体功能障碍
J Endocr Soc. 2017 Jun 1;1(7):931-944. doi: 10.1210/js.2017-00192. eCollection 2017 Jul 1.
5
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.非酒精性脂肪性肝病、非酒精性脂肪性肝炎及相关纤维化的诊断方法。
Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.
6
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的当前和未来治疗方案。
Hepatology. 2018 Jul;68(1):361-371. doi: 10.1002/hep.29724.
7
Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.磁共振成像肝质子密度脂肪分数对儿童非酒精性脂肪性肝病的诊断准确性。
Hepatology. 2018 Mar;67(3):858-872. doi: 10.1002/hep.29596. Epub 2018 Jan 26.
8
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.对非酒精性脂肪性肝病流行情况的建模显示,疾病负担呈指数级增长。
Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.
9
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).NASPGHAN儿童非酒精性脂肪性肝病诊断与治疗临床实践指南:非酒精性脂肪性肝病专家委员会(ECON)及北美儿科胃肠病学、肝病学和营养学会(NASPGHAN)的建议
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.
10
Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance.肝脂肪变性在肥胖和多囊卵巢综合征青少年中很常见,且与从头脂肪生成有关,但与胰岛素抵抗无关。
Obesity (Silver Spring). 2016 Nov;24(11):2399-2406. doi: 10.1002/oby.21651.